BriaCell Therapeutics Corp. (BCTX) Other Non Operating Income (2021 - 2026)

BriaCell Therapeutics has reported Other Non Operating Income for 6 years, with the latest figure at -$2619.0 in Q2 2026.

• Quarterly Other Non Operating Income fell 547.69% year-over-year to -$2619.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$47707.0 (down 721.67% YoY) and the FY2025 annual result came in at -$24941.0, up 2.01% from the prior year.
• Other Non Operating Income advanced to -$2619.0 in Q2 2026 per BCTX's latest filing, from -$21049.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $20677.0 in Q4 2025 and troughed at -$44716.0 in Q3 2025.
• A 5-year average of -$6945.6 and a median of -$6286.5 in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 28138.24% in 2022, then surged 62100.0% in 2025.
• Over 5 years, Other Non Operating Income stood at -$9533.0 in 2022, then fell by 15.32% to -$10993.0 in 2023, then surged by 87.85% to -$1336.0 in 2024, then surged by 1647.68% to $20677.0 in 2025, then slumped by 112.67% to -$2619.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$2619.0, -$21049.0, and $20677.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.